Baloxavir Marboxil
Last Updated: 04/28/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 304 publications
Antiviral activities of multiple antivirals against highly pathogenic avian influenza A H5N1 in vitro and in mice.
Journal: Emerging microbes & infections
Published: March 31, 2026
Report on influenza viruses received and tested by the Melbourne WHO Collaborating Centre for Reference and Research on Influenza during 2024.
Journal: Communicable diseases intelligence (2018)
Published: February 23, 2026
Baloxavir Acid-Induced Mitochondrial Toxicity and Cell Cycle Arrest Contribute to Its Adverse Effects.
Journal: International journal of molecular sciences
Published: February 10, 2026
Psychiatric Symptoms after H1N1 Influenza Treated with Baloxavir Marboxil in Two Patients with Hematologic Malignancies.
Journal: Mediterranean journal of hematology and infectious diseases
Published: February 05, 2026
Emergence of the novel PA-D27G mutation conferring reduced baloxavir susceptibility in influenza A viruses circulating in China, 2018-2025.
Journal: Emerging microbes & infections
Published: January 20, 2026
In silico evaluation of FDA-approved antivirals and corticosteroids against SARS-CoV-2.
Journal: Scientific reports
Published: January 16, 2026
Baloxavir susceptibility of seasonal influenza viruses during the first seven seasons of clinical use in Japan, 2017/18 to 2023/24.
Journal: Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin
Published: January 09, 2026
V-domain immunoglobulin suppressor of T-cell activation regulates CD4+ T cell activation and podocyte function through PI3K/AKT signaling pathway.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: November 07, 2025
Comprehensive evaluation of therapeutic effectiveness and safety profiles of baloxavir marboxil for managing influenza virus infection in pediatric populations: a systematic review with pooled meta-analytic data.
Journal: Frontiers in pediatrics
Published: October 27, 2025
Comparison table: Antiviral drugs for seasonal influenza for 2025-2026.
Journal: The Medical letter on drugs and therapeutics
Published: October 21, 2025
Antiviral drugs for seasonal influenza for 2025-2026.
Journal: The Medical letter on drugs and therapeutics
Published: October 21, 2025
Exploring Drug Repurposing for Influenza A (H3N2) Virus: A Computational Approach to Identifying Commercialized Drugs Targeting Hemagglutinin, Neuraminidase, and Nucleoprotein.
Journal: Journal of chemical information and modeling
Published: October 18, 2025
Last Updated: 04/28/2026